Tetramune Interactions
There are 304 drugs known to interact with Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), along with 4 disease interactions. Of the total drug interactions, 1 is major, 300 are moderate, and 3 are minor.
- View all 304 medications that may interact with Tetramune
- View Tetramune disease interactions (4)
Most frequently checked interactions
View interaction reports for Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid) and the medicines listed below.
- acyclovir
- Adacel (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- alprazolam
- amoxicillin
- Cipro (ciprofloxacin)
- Citrucel (methylcellulose)
- Colace (docusate)
- cranberry
- cyanocobalamin
- dexamethasone
- diflorasone topical
- doxepin
- fenofibrate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flublok (influenza virus vaccine, inactivated)
- Flucelvax (influenza virus vaccine, inactivated)
- fluticasone nasal
- Havrix (hepatitis a adult vaccine)
- hepatitis b pediatric vaccine
- influenza virus vaccine, inactivated
- Lexapro (escitalopram)
- LoHist-12 (brompheniramine)
- magnesium oxide
- measles virus vaccine / mumps virus vaccine / rubella virus vaccine
- meningococcal group B vaccine
- metformin
- methylprednisolone
- MethylPREDNISolone Dose Pack (methylprednisolone)
- Moderna COVID-19 Vaccine (COVID-19 mRNA (Moderna) vaccine)
- zoster vaccine live
Tetramune disease interactions
There are 4 disease interactions with Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid) which include:
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.